Antitumor activities with a recombinant endoglin-MIP3a/Fc fusion protein as a model antigen

被引：0
|
作者：
He, Z. [1 ]
Liu, S. [1 ]
Lu, Y. [1 ]
Huang, Y. [1 ]
Guo, J. [1 ]
Zheng, S. [1 ]
机构：
[1] Hainan Med Univ, Affiliated Hosp 1, Tumor Inst, Haikou, Hainan, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P1671
引用
收藏
页码：1675 / 1676
页数：2
相关论文
共 50 条
  • [21] A recombinant anti-erbB2, scFv-Fc-IL-2 fusion protein retains antigen specificity and cytokine function
    Ming Shi
    Zhigang Xie
    Jiannan Feng
    Yingxun Sun
    Ming Yu
    Beifen Shen
    Ning Guo
    Biotechnology Letters, 2003, 25 : 815 - 819
  • [22] Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B-LONG trial
    Sidonio Jr, Robert F.
    Casiano, Sandra
    Falk, Aletta
    Altincatal, Arman
    Katragadda, Suresh
    Santagostino, Elena
    Windyga, Jerzy
    HAEMOPHILIA, 2023, 29 (01) : 404 - 407
  • [23] A Novel, Enriched Population Pharmacokinetic Model for Recombinant Factor VIII-Fc Fusion Protein Concentrate in Hemophilia A Patients
    Bukkems, Laura H.
    Heijdra, Jessica M.
    Mathias, Mary
    Collins, Peter W.
    Hay, Charles R. M.
    Tait, Robert C.
    Mangles, Sarah
    Myers, Bethan
    Evans, G.
    Bailiff, Benjamin
    Curry, Nicola
    Payne, Jeanette
    Austin, Steve
    Goedhart, Tine M. H. J.
    Leebeek, Frank W. G.
    Meijer, Karina
    Fijnvandraat, Karin
    Chowdary, Pratima
    Mathot, Ron A. A.
    Cnossen, Marjon H.
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (05) : 747 - 757
  • [24] Evaluation of the toxicology and pharmacokinetics of recombinant factor VIII Fc (rFVIIIFc) fusion protein in animals
    Dumont, Jennifer A.
    Loveday, Ken
    Light, David R.
    Pierce, Glenn F.
    Jiang, Haiyan
    HAEMOPHILIA, 2014, 20 : 21 - 21
  • [25] Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
    Powell, Jerry S.
    Josephson, Neil C.
    Quon, Doris
    Ragni, Margaret V.
    Cheng, Gregory
    Li, Ella
    Jiang, Haiyan
    Li, Lian
    Dumont, Jennifer A.
    Goyal, Jaya
    Zhang, Xin
    Sommer, Jurg
    McCue, Justin
    Barbetti, Margaret
    Luk, Alvin
    Pierce, Glenn F.
    BLOOD, 2012, 119 (13) : 3031 - 3037
  • [26] Recombinant factorVIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A
    Young, G.
    Mahlangu, J.
    Kulkarni, R.
    Nolan, B.
    Liesner, R.
    Pasi, J.
    Barnes, C.
    Neelakantan, S.
    Gambino, G.
    Cristiano, L. M.
    Pierce, G. F.
    Allen, G.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) : 967 - 977
  • [27] Biochemical and functional characterization of a recombinant monomeric factor VIII-Fc fusion protein
    Peters, R. T.
    Toby, G.
    Lu, Q.
    Liu, T.
    Kulman, J. D.
    Low, S. C.
    Bitonti, A. J.
    Pierce, G. F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 (01) : 132 - 141
  • [28] A SIRPα-Fc fusion protein enhances the antitumor effect of oncolytic adenovirus against ovarian cancer
    Huang, Yao
    Lv, Sai-qun
    Liu, Pin-yi
    Ye, Zhen-long
    Yang, Huan
    Li, Lin-fang
    Zhu, Hai-li
    Wang, Ying
    Cui, Lian-zhen
    Jiang, Du-qing
    Hao, Fang-yuan
    Xu, Hui-min
    Jin, Hua-jun
    Qian, Qi-jun
    MOLECULAR ONCOLOGY, 2020, 14 (03) : 657 - 668
  • [29] Recombinant canine IgE Fc and an IgE Fc-TRAIL fusion protein bind to neoplastic canine mast cells
    Elders, R. C.
    Holder, A.
    Smith, K. C.
    Baines, S. J.
    Catchpole, B.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2014, 159 (1-2) : 29 - 40
  • [30] Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein
    Barsoum, Adel L.
    Liu, Bainan
    Rohrer, James W.
    Coggin, Joseph H., Jr.
    Tucker, J. Allan
    Pannell, Lewis K.
    Schwarzenberger, Paul O.
    BIOMATERIALS, 2009, 30 (17) : 3091 - 3099
12345